Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Tekmira Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Feb 2015 Reuters Investment Profile 12 $20.00

Arbutus Biopharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

07 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Arbutus Biopharma Corp (ABUS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

20 May 2016 Thomson Reuters Stock Report 12 $25.00

Thomson Reuters Stock Report - Arbutus Biopharma Corp (ABUS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

13 May 2016 Thomson Reuters Stock Report 12 $25.00

ABUS: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

13 May 2016 New Constructs, LLC 10 $25.00

ValuEngine Rating and Forecast Report for ABUS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

08 May 2016 ValuEngine, Inc. 11 $25.00

ARBUTUS BIOPHARMA CP (ABUS=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

07 May 2016 Pechala's Reports 2 $25.00

Value Graph: ARBUTUS BIOPHARM -- ABUS

06 May 2016 Ford Investor Services, Inc. 1 $12.00

Industry Value Graph: ABUS -- DRUGS

06 May 2016 Ford Investor Services, Inc. 3 $35.00

ABUS.OQ - Event Transcript of Arbutus Biopharma Corp conference call, May 04, 2016 / 4:30PM ET

Edited Event Transcript of ABUS.OQ conference call, May 04, 2016 / 4:30PM ET Boston, May 4, 2016 (Thomson StreetEvents)...

04 May 2016 Thomson Reuters StreetEvents 11 $75.00